Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Sutro Biopharma (STRO) Debt Ratio (2017 - 2023)

Sutro Biopharma (STRO) has disclosed Debt Ratio for 7 consecutive years, with 0.01 as the latest value for Q4 2023.

  • Quarterly Debt Ratio fell 78.42% to 0.01 in Q4 2023 from the year-ago period, while the trailing twelve-month figure was 0.01 through Dec 2023, down 78.42% year-over-year, with the annual reading at 0.01 for FY2023, 78.42% down from the prior year.
  • Debt Ratio hit 0.01 in Q4 2023 for Sutro Biopharma, down from 0.02 in the prior quarter.
  • In the past five years, Debt Ratio ranged from a high of 0.16 in Q1 2020 to a low of 0.01 in Q4 2023.
  • Historically, Debt Ratio has averaged 0.06 across 5 years, with a median of 0.07 in 2019.
  • Biggest five-year swings in Debt Ratio: soared 122.78% in 2020 and later plummeted 78.42% in 2023.
  • Year by year, Debt Ratio stood at 0.06 in 2019, then dropped by 1.39% to 0.06 in 2020, then grew by 18.11% to 0.07 in 2021, then tumbled by 45.64% to 0.04 in 2022, then plummeted by 78.42% to 0.01 in 2023.
  • Business Quant data shows Debt Ratio for STRO at 0.01 in Q4 2023, 0.02 in Q3 2023, and 0.02 in Q2 2023.